TEVA-MOMETASONE

Google image searchProduct monograph

Active ingredient

mometasone furoate, 50 MCG/ACT

DIN: 02475863

Dosage form(s): SPRAY, METERED DOSE

Route(s) of administration: NASAL

Description: SUSPENSION

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 02-OCT-2018

ATC:

• R01 — NASAL PREPARATIONS (ATC, ATC/DDD, )
• R01A — DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (ATC, ATC/DDD)
• R01AD — Corticosteroids (ATC, ATC/DDD)
• R01AD09 — MOMETASONE (ATC/DDD)

Reference brand drug: Nasonex

Pharmaceutical standard: MFR

External Links for Teva-Mometasone

Search on Google

• Teva-Mometasone side effects
• Teva-Mometasone dosage
• mometasone furoate side effects
• mometasone furoate dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-mometasone photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.